Dr. David O'Reilly, BAT: New-to-world, plant-based research towards a COVID-19 vaccine скачать в хорошем качестве

Dr. David O'Reilly, BAT: New-to-world, plant-based research towards a COVID-19 vaccine

Dr David O’Reilly, Plant Virologist and Director of Scientific Research at BAT details how a potential antigen in fast-growing, genetically engineered tobacco plants is being engineered. Directed from Southampton, UK, and undertaken in Kentucky, USA, scientists cloned a portion of the virus's genetic sequence and fused it to a novel tobacco virus antigen, a protein that induces the production of antibodies and enables the body's immune system to prevent infection. Unlike conventional vaccines often requiring refrigeration, this novel formulation is quickly manufactured and stable at room temperature, offering a potential gamechanger for developing countries. The same research team received FDA Emergency Use Authorisation for a tobacco-based treatment for Ebola and has recently commenced clinical studies for a rapid-response novel Quadrivalent Influenza Vaccine (QIV). COVID-19: Plant-based vaccines in an unusual place - tobacco Dr. David O'Reilly's exclusive interview with the Financial Times Science Editor, Clive Cookson    • COVID-19:  Plant Based Vaccines in an Unus...   ©SciCom https://www.sci-com.eu